Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Prism Pharmaceuticals
Develops and commercializes branded cardiovascular injectable products
King of Prussia, PA
NYSE: BAX
Contact:
Formerly Known As: Prism Pharmaceuticals
Acquisition
Acquired by: Baxter International
Exit date: April 18, 2011
Related News
Baxter Announces the Acquisition of Prism
Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use NEXTERONE® (amiodarone HCl) Premixed Inj